喹诺酮类药物对社区医院分离出的厌氧菌的比较活性。
Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals.
作者信息
Goldstein E J, Citron D M
出版信息
Antimicrob Agents Chemother. 1985 Apr;27(4):657-9. doi: 10.1128/AAC.27.4.657.
Abstract
The in vitro activity of five quinolone compounds, amoxicillin, and clindamycin against 118 strains of anaerobic bacteria isolated at community hospitals was determined by an agar dilution method. Nalidixic acid and cinoxacin had poor activity, and norfloxacin and enoxacin showed relatively poor activity. Ciprofloxacin was active against Bacteroides fragilis, Fusobacterium species, Clostridium perfringens, and gram-positive cocci. At peak levels achievable in the feces, norfloxacin and enoxacin had moderate activity.
摘要
采用琼脂稀释法测定了5种喹诺酮类化合物、阿莫西林和克林霉素对社区医院分离出的118株厌氧菌的体外活性。萘啶酸和西诺沙星活性较差，诺氟沙星和依诺沙星活性相对较弱。环丙沙星对脆弱拟杆菌、梭杆菌属、产气荚膜梭菌和革兰氏阳性球菌有活性。在粪便中可达到的峰值水平时，诺氟沙星和依诺沙星具有中等活性。
相似文献
1
Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals.
Antimicrob Agents Chemother. 1985 Apr;27(4):657-9. doi: 10.1128/AAC.27.4.657.
2
Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.
Antimicrob Agents Chemother. 1985 Feb;27(2):162-6. doi: 10.1128/AAC.27.2.162.
3
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
J Antimicrob Chemother. 1986 Nov;18 Suppl D:1-20. doi: 10.1093/jac/18.supplement_d.1.
4
Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals.
Antimicrob Agents Chemother. 1986 Jan;29(1):158-60. doi: 10.1128/AAC.29.1.158.
5
[Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin].
Pathol Biol (Paris). 1985 Nov;33(9):899-903.
6
Susceptibility of anaerobic bacteria to PD 131628.
Eur J Clin Microbiol Infect Dis. 1992 Jan;11(1):68-71. doi: 10.1007/BF01971277.
7
In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.
Eur J Clin Microbiol Infect Dis. 1993 Aug;12(8):640-2. doi: 10.1007/BF01973648.
8
[Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
Enferm Infecc Microbiol Clin. 1991 Apr;9(4):219-22.
9
Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.
Scand J Infect Dis. 1986;18(2):149-51. doi: 10.3109/00365548609032321.
10
Comparative in vitro activity of Ro 40-6890, Ro 41-3399, and other antimicrobial agents against anaerobic bacteria.
Eur J Clin Microbiol Infect Dis. 1992 Oct;11(10):946-9. doi: 10.1007/BF01962382.
引用本文的文献
1
Quinolone activity against anaerobes.
Drugs. 1999;58 Suppl 2:60-4. doi: 10.2165/00003495-199958002-00012.
2
In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infections.
Antimicrob Agents Chemother. 1998 Apr;42(4):984-6. doi: 10.1128/AAC.42.4.984.
3
In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.
Antimicrob Agents Chemother. 1996 Sep;40(9):2232-5. doi: 10.1128/AAC.40.9.2232.
4
Quinolone activity against anaerobes: microbiological aspects.
Drugs. 1995;49 Suppl 2:76-80. doi: 10.2165/00003495-199500492-00012.
5
In vitro activity of Bay Y3118 against anaerobic bacteria.
Antimicrob Agents Chemother. 1993 Nov;37(11):2509-13. doi: 10.1128/AAC.37.11.2509.
6
Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
Antimicrob Agents Chemother. 1993 Aug;37(8):1649-54. doi: 10.1128/AAC.37.8.1649.
7
Comparative activities of eight quinolones against members of the Bacteroides fragilis group.
Antimicrob Agents Chemother. 1994 Jun;38(6):1442-5. doi: 10.1128/AAC.38.6.1442.
8
Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria.
Antimicrob Agents Chemother. 1987 Sep;31(9):1379-82. doi: 10.1128/AAC.31.9.1379.
9
Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.
Antimicrob Agents Chemother. 1986 Oct;30(4):574-6. doi: 10.1128/AAC.30.4.574.
10
Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.
Pharm Weekbl Sci. 1986 Feb 21;8(1):1-21. doi: 10.1007/BF01975473.
本文引用的文献
1
In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives.
Antimicrob Agents Chemother. 1984 Apr;25(4):518-21. doi: 10.1128/AAC.25.4.518.
2
In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.
J Antimicrob Chemother. 1984 Mar;13(3):237-44. doi: 10.1093/jac/13.3.237.
3
Epidemiology and susceptibility of resistant Bacteroides fragilis group organisms to new beta-lactam antibiotics.
Rev Infect Dis. 1984 Mar-Apr;6 Suppl 1:S254-9. doi: 10.1093/clinids/6.supplement_1.s254.
4
Mechanisms of resistance and resistance transfer in anaerobic bacteria: factors influencing antimicrobial therapy.
Rev Infect Dis. 1984 Mar-Apr;6 Suppl 1:S260-9. doi: 10.1093/clinids/6.supplement_1.s260.
5
Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers.
Antimicrob Agents Chemother. 1984 Jul;26(1):110-1. doi: 10.1128/AAC.26.1.110.
6
In-vitro studies with ciprofloxacin, a new 4-quinolone compound.
J Antimicrob Chemother. 1984 Apr;13(4):333-46. doi: 10.1093/jac/13.4.333.
7
The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.
J Antimicrob Chemother. 1984 Apr;13(4):325-31. doi: 10.1093/jac/13.4.325.
8
In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
Antimicrob Agents Chemother. 1983 Nov;24(5):754-63. doi: 10.1128/AAC.24.5.754.
9
Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
Antimicrob Agents Chemother. 1983 Aug;24(2):302-4. doi: 10.1128/AAC.24.2.302.
10
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.
Antimicrob Agents Chemother. 1983 Apr;23(4):559-64. doi: 10.1128/AAC.23.4.559.
Zotero 插件